Scientists of the Michigan University have developed a new method for diagnosis of localized prostate cancer. According to the authors, it is more accurate than PSA test.
A new method – Mi-Prostate Score – is urine analysis for the presence of two molecular markers of prostate cancer in the sample.
This complements the traditional blood test during a PSA test and can detect tumors in early stage with high precision and to assess the level of aggressiveness.
The effectiveness of the new method was studied on 2 thousand urine samples. The study found that almost half of the cases of prostate cancer had fusion of two genes.